News from the AAN Annual Meeting: Hyperosmolar Therapy Yields Worse Results in Primary ICH Patients, Database Review Shows

 – June 5, 2014  –– 

In a prospective review of data from one of the largest registries on intracerebral hemorrhage outcomes, researchers observed that those who had received hyperosmolar therapy had worse outcomes than those who did not receive the treatment. “Statistical attempts to match patient groups that are fundamentally different have limitations,” said Stephan Mayer, MD, Professor of Neurology and Neurological Surgery and Director of the Institute for Critical Care Medicine at the Icahn School of Medicine at Mount Sinai, who was not involved with the study. “You can basically match or control for certain variables related to disease severity but you really can't control for everything.”

-Dr. Stephan Mayer, Professor, Neurology, Neurological Surgery, Director, Institute for Critical Care Medicine, Icahn School of Medicine at Mount Sinai

Learn more